Abstract
The synthesis and physicochemical characterization of febuxostat (FEB) cocrystals, a xanthine oxidase inhibitor, with pharmaceutically acceptable coformers, such as urea (URE), acetamide (ACT), nicotinamide (NIC), p-aminobenzoic acid (PABA), and saccharin (SAC) (all of 1:1 stoichiometry), are reported. X-ray crystal structures were determined for FEB drug and its cocrystals with URE, ACT, NIC, and PABA, whereas the SAC cocrystal was characterized by FT-IR-Raman, differential scanning calorimetry (DSC), 13C ss-NMR, and powder X-ray diffraction. The crystal structure of FEB has O–H···N hydrogen bonds (COOH···N≡C) instead of the expected acid–acid homodimer synthon. The cocrystal structures are sustained by the cyclic synthons acid–amide (FEB–URE, FEB–NIC) and acid–acid (FEB–PABA), while FEB–ACT has no distinct ring motif. The cocrystals exhibited a higher intrinsic dissolution rate (IDR) compared to FEB and good stability in accelerated ICH humidity conditions of 75% RH at 40 °C.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
